Hence, the use of decitabine to render tumor cells susceptible to killing by CSPG4-CAR-T cells is not exclusively restricted to SKOV-3 cells, but works also in other ovarian cancer cells, such as Caov-3, and neoplastic cells such as 293T. Here, CSPG4 is linked to ovarian cancer.